X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.businesswire.com/news/home/20210322005101/en/Lantheus-Announces-Presentation-Featuring-AZEDRA%C2%AE-iobenguane-I-131-at-ENDO-2021#:~:text=Business%20Wire-,Lantheus%20Announces%20Presentation%20Featuring%20AZEDRA%C2%AE,I%20131)%20at%20ENDO%202021&text=NORTH%20BILLERICA%2C%20Mass.%2D%2D(BUSINESS,WIRE)%2D%2DLantheus%20Holdings%2C%20Inc.&text=%E2%80%9CAZEDRA%20is%20the%20first%20and,Chief%20Medical%20Officer%20of%20Lantheus.
https://www.fiercebiotech.com/medtech/lantheus-to-buy-progenics-to-chase-both-cancer-imaging-diagnostics-and-therapeutics
https://www.reuters.com/article/us-progenics-pharm-fda/fda-approves-progenics-treatment-for-rare-adrenal-gland-tumors-idUSKBN1KK2C2
https://www.biospace.com/article/fda-approves-progenics-pharma-s-azedra-for-ultra-rare-cancers/
https://globenewswire.com/news-release/2018/07/31/1544259/0/en/Progenics-Pharmaceuticals-Announces-FDA-Approval-for-AZEDRA-iobenguane-I-131-to-Treat-Unresectable-Locally-Advanced-or-Metastatic-Pheochromocytoma-or-Paraganglioma.html
https://pharmaphorum.com/cancer/fda-approves-first-drug-to-treat-rare-adrenal-cancer/
https://www.fiercepharma.com/pharma/progenics-snags-fda-nod-for-300k-cancer-fighter-azedra
https://endpts.com/fda-approves-cancer-radiation-drug-azedra-sending-progenics-stock-north/
https://www.reuters.com/article/progenics-pharm-fda/fda-approves-progenics-treatment-for-two-rare-tumors-idUSL4N1UQ5EU?rpc=401&
https://www.prnewswire.com/news-releases/fda-approves-first-treatment-for-rare-adrenal-tumors-300688662.html
Market Place
Share 
